- Home
- INMD vs SABR Comparison
INMD vs SABR Comparison
Compare INMD & SABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMD
- SABR
- Stock Information
- Founded
- INMD 2008
- SABR 2006
- Country
- INMD Israel
- SABR United States
- Employees
- INMD N/A
- SABR N/A
- Industry
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SABR Computer Software: Programming Data Processing
- Sector
- INMD Health Care
- SABR Technology
- Exchange
- INMD Nasdaq
- SABR Nasdaq
- Market Cap
- INMD 964.9M
- SABR 836.4M
- IPO Year
- INMD 2019
- SABR 2014
- Fundamental
- Price
- INMD $14.53
- SABR $2.00
- Analyst Decision
- INMD Hold
- SABR Buy
- Analyst Count
- INMD 6
- SABR 5
- Target Price
- INMD $17.06
- SABR $4.12
- AVG Volume (30 Days)
- INMD 774.5K
- SABR 7.6M
- Earning Date
- INMD 11-05-2025
- SABR 11-05-2025
- Dividend Yield
- INMD N/A
- SABR N/A
- EPS Growth
- INMD 20.42
- SABR N/A
- EPS
- INMD 2.21
- SABR 1.41
- Revenue
- INMD $364,494,000.00
- SABR $3,034,040,000.00
- Revenue This Year
- INMD N/A
- SABR N/A
- Revenue Next Year
- INMD $5.02
- SABR $3.91
- P/E Ratio
- INMD $6.57
- SABR $1.41
- Revenue Growth
- INMD N/A
- SABR 6.07
- 52 Week Low
- INMD $13.14
- SABR $1.69
- 52 Week High
- INMD $19.85
- SABR $4.63
- Technical
- Relative Strength Index (RSI)
- INMD 40.07
- SABR 53.52
- Support Level
- INMD $14.48
- SABR $1.86
- Resistance Level
- INMD $15.86
- SABR $2.17
- Average True Range (ATR)
- INMD 0.41
- SABR 0.13
- MACD
- INMD -0.13
- SABR 0.00
- Stochastic Oscillator
- INMD 20.74
- SABR 47.07
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
About SABR Sabre Corporation
Sabre holds the number-two air booking volume share in the global distribution system industry. The travel solutions segment represented 91% of total 2024 revenue, split between distribution (79% of segment sales) and airline IT solutions (21%) revenue. The company sold its growing hotel IT solutions division (9% of revenue) to TPG in 2025 for $960 million in net proceeds. Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.